Skip to content
BY 4.0 license Open Access Published by De Gruyter Open Access March 10, 2020

Chemical composition and in vitro activity of Origanum vulgare L., Satureja hortensis L., Thymus serpyllum L. and Thymus vulgaris L. essential oils towards oral isolates of Candida albicans and Candida glabrata

  • Tomasz Baj EMAIL logo , Anna Biernasiuk , Rafał Wróbel and Anna Malm
From the journal Open Chemistry


The purpose of this research was to investigate the chemical composition of essential oils (EOs) from: Origanum vulgare L., Satureja hortensis L., Thymus serpyllum L. and Thymus vulgaris L. (Lamiaceae) cultivated in Poland, and to study their antifungal activity towards clinical isolates of oral Candida spp. The hydrodistilled essential oils were analyzed using the GC-MS method. The antifungal activity was evaluated in vitro against oral isolates and reference strains of Candida albicans and C. glabrata, using the broth microdilution method according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) guidelines, allowing for estimation of minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC). GC-MS analysis revealed that carvacrol was the main EO compound in oregano and summer savory, while thymol and linalool were the major ingredients of thyme and wild thyme oils, respectively. The EOs possessed fungicidal activity against C. albicans and C. glabrata, including oral isolates, with MIC = 125 – 2000 mg/L, MFC = 250 – 4000 mg/L and MFC/MIC = 1 – 4, depending on the yeast and plant species. The most active was thyme oil – with MIC = 125 – 500 mg/L, MFC = 250 – 500 mg/L and MFC/MIC = 1 – 2.

1 Introduction

The yeasts from genus Candida, covering about 280 species, are a part of the microbiota colonizing mucocutaneus areas, with a reported prevalence of 15-75%, mainly within the oral cavity, upper airways, gastrointestinal tract and vagina of healthy individuals. Simultaneously, Candida spp., especially Candida albicans and Candida glabrata (the last listed under the collective non-albicans Candida species listing [NAC]) are the most important cause of opportunistic infections worldwide, affecting predominantly immunocompromised or hospitalized patients, as well as the elderly population [1, 2, 3]. Candida spp. is associated with candidiases, including different diseases that range from superficial infections (e.g. oropharyngeal candidiases), to life threatening systemic disorders. Several factors may contribute to the pathogenic potential of C. albicans, e.g. growth in two forms, unicellular and filamentous, to adherence to the mucosal tissues and the production of extracellular enzymes [2]. C. albicans is the most common species isolated from the oral cavity (in 40% of the entire population) [1]. In turn, the incidence of C. glabrata is difficult to determine since this species is rarely isolated alone and is often co-isolated with C. albicans. It currently ranks second or third as the causative agent of Candida infections [4].

During the last decades, a constantly increasing number of fungal diseases caused by resistant strains of different Candida species [2] have established themselves within the human population. Insufficient effectiveness of some azole preparations and higher toxicity of polyene antibiotics has stimulated the search for new natural antifungal compounds. One of the most promising natural alternatives to traditional antifungal preparations are the essential oils (EOs) drawn from medicinal plants. Many of the natural products containing EOs and their constituents have antimicrobial properties, while several studies have shown high sensitivity of pathogenic fungi, including yeasts, to EOs [2,5, 6, 7, 8]. According to Waller et al. [9, 10, 11], 55 botanical species belonging to 27 genus exhibit antifungal effects, especially the aromatic plants, notably Origanum vulgare L., Satureja hortensis L., Thymus serpyllum L. and Thymus vulgaris L. from the Lamiaceae family. These plants are a rich source of EOs [6,12,13], the major components of which may belong to several classes of compounds, mainly terpenes, such as thymol and carvacrol [12,14]. Other isolated chemical molecules from Lamiaceae, among others, estragole, 1,8-cineole, terpineol-4-ol, γ-terpinene were also described as promising for use as antifungals in mycoses [9]. However, it is necessary to identify the most effective compounds in order to extract or synthesize in pure form for future use in the pharmaceutical industry. It is also imperative that essential oils should be further examined, so that safe conclusions can be drawn about their potential use the antifungal agents [8].

The purpose of the work was to analyze the chemical composition of EOs from: Origanum vulgare L., Satureja hortensis L., Thymus serpyllum L. and Thymus vulgaris L. cultivated in Poland, and to assess their antifungal activity against oral isolates of Candida spp.

2 Materials and Methods

2.1 Raw materials and essential oils

This study used the following commercial raw materials (herbs): oregano (O. vulgare L.), summer savory (S. hortensis L.), thyme (T. vulgaris L.) (mfg. Dary Natury, Poland) and wild thyme (T. serpyllum L.) (mfg. Flos, Poland) which were all purchased from a local herbal store (Lublin, Poland). All raw materials were before their expiration date. The EOs were obtained by way of the hydrodistillation method, using the Deryng-type apparatus, according to previously described procedure [15]. The EOs were dried over anhydrous Na2SO4, stored in a dark glass bottle and kept at 4oC until analysis.

2.2 GC/MS analysis

Gas chromatography – mass spectrometry (GC-MS) analysis was performed utilizing a Shimadzu GC-2010 Plus, coupled to a Shimadzu QP2010 Ultra mass spectrometer, according to the method described by Skalicka-Wozniak et al. [16]. The separation of compounds was obtained by employing a fused-silica capillary column ZB-5 MS (30 m, 0.25 mm i.d.) with a film thickness of 0.25 μm (Phenomenex) via temperature gradient (50°C for 3 min., then a constant increase up to 250°C during 25 min, after which 250°C was held for 2 min). The temperatures of 250°C, 250°C, and 220°C were kept for the injector, interface and ion source, respectively. Helium was the carrier gas, the flow rate being 1 mL/min, while the split ratio was 1:20. Ions were produced by way of the electron impact method at 70 eV. The scan mode was in the m/z range 40–500, while the scan rate of 0.20 s per scan was applied for data acquisition. Finally, a homologous series of n-alkanes (C8–C24) were used to determine the retention indices under the same operating conditions. The identification was performed using MS data from the NIST Database [17].

2.3 Tested microorganisms

The study used the reference strains – Candida albicans ATCC 10231, C. albicans ATCC 2091 and Candida glabrata ATCC 90030, as well as 30 clinical strains of C. albicans (15 isolates) and C. glabrata (15 isolates) obtained from the oral mucosa of hospitalized patients, including cancer patients, patients with chronic hepatitis C or diabetes mellitus and elderly people. The isolates were identified by standard diagnostic methods. All the used microbial cultures were stored at -70°C, and then subcultured on the Sabouraud agar at 30°C for 24-48 h.

2.4 Estimation of minimal inhibitory concentration (MIC) and minimal fungicidal concentration (MFC)

The antifungal activities of EOs were screened in vitro by applying the broth microdilution method according to the recommendation of European Committee on Antimicrobial Susceptibility Testing (EUCAST) [18] and Clinical and Laboratory Standards Institute (CLSI) guidelines [19]. Samples containing these EOs were dissolved in dimethyl sulfoxide (DMSO). The stock solution of EOs was 50 000 mg/L). Subsequently, the MIC (Minimal Inhibitory Concentration) of the compounds was examined by applying the microdilution broth method, using their two-fold dilutions (from 8 000 to 62.5 mg/ L) in RPMI 1640 broth with MOPS. In this method, 96-well microtiter plates were used; then, yeast suspensions of 0.5 McFarland standard in sterile saline were prepared in each isolate using a densitometer. The yeast suspension was added (1 μl) to each well. The last wells containing only RPMI with the MOPS medium without EOs served as the positive growth control. In turn, the wells with medium and EOs but without yeast inoculum served as the negative control. The microtiter plates were incubated at 35oC for 24 h. The optical density of yeast growth in each well was estimated using the ELx800 microtiter plate reader (Biotek) connected with the KC Juniors for Windows computer program. The MIC was read as the lowest concentration of EOs which prevented growth of a given yeast isolate.

In turn, after MIC readings, MFC (Minimal Fungicidal Concentration) was determined. The inocula from each well which showed a completed growth inhibition and from the last positive well (growth similar to the growth control well), and from the growth control for each isolate were subcultured on Sabouraud agar plates, and incubated as before. The MFC showed the lowest EO concentration that showed either no growth or fewer than three colonies to obtain approximately 99 to 99.5% killing activity. The studies were carried out in accordance with previously described procedures [20]. Nystatin and chlorhexidine (Sigma-Aldrich) were used as reference antifungal compounds (positive controls). The MFC/MIC ratios were calculated to determine the fungicidal (MFC/ MIC ≤ 4) or fungistatic (MFC/MIC > 4) effect of the tested EOs [20]. Moreover, the values of MIC50 and MIC90 or MFC50 and MFC90 – minimal inhibitory concentrations or minimal fungicidal concentrations of EOs, which inhibit or kill 50% or 90% of the tested isolates, were also established.

Ethical approval: The Ethics Committee of the Medical University of Lublin approved the study protocol (No. KE-0254/75/2011).

3 Results and Discussion

Today there are several classes of antifungal drugs available for the treatment of fungal infections in humans. In oral candidiases, various antimycotics have been used as antiseptic agents, with fluconazole, nystatin suspension and chlorhexidine commonly applied topically as mouthwash [21]. However, several studies have been performed to search for natural compounds with antifungal activity, especially among aromatic plants due to their high content of biologically active compounds, mainly EOs [5,6,14].

It is well known that the composition, quality and content of EOs are subject to a great variation and are influenced by diverse factors such as the geographical and climatic conditions, as well as the conditions used for culture, drying and storage, the harvesting season, or differences in oil extraction techniques. Consequently, these variations can have a repercussion on the biological activity of EOs [7,10,11].

3.1 Chemical composition of essential oils

Using the GC/ MS method, 21 to 34 chemical components of the examined oils, were identified. Wild thyme oil (T. serpyllum L.) showed the highest number of these ingredients – 34 components. In turn, 23 and 25 components were found in summer savory (S. hortensis L.) and thyme oils (T. vulgaris L.), respectively. The least number of components (21), were identified in oregano oil (O. vulgare L.). The content of individual volatile components of the examined essential oils was presented as their percentage share among the detected compounds. Significant amounts of carvacrol (50.7%), γ-terpinene (24.3%) and p-cymene (12.5%) were found in the savory oil components,. Similarly, a high carvacrol content (57.3%) was detected in oregano EO. Additionally, among the identified components of this oil, 1,8-cineole (12.9%) and α-pinene (7.9%) were in significant amounts. In turn, oil of wild thyme included a large percentage of linalool (30.9%) and thymol (25.1%), and slightly less geraniol (10.5%) and p-cymene (5.3%). Thyme EO showed the largest content of thymol (75.2%), and also showed a lower content of carvacrol (7.7%) and p-cymene (6.3%). In these EOs, the remaining components were present in smaller amounts (Table 1).

Table 1

Percentage composition of volatile components identified from: Origanum vulgare, Satureja hortensis, Thymus serpyllum, and Thymus vulgaris L. essential oils (n=3).

No.CompoundRI*Relative percentage (%)
121,8 - Cineole105912.90.50.4
14cis-Sabinene hydrate10750.20.4
25Thymol methyl ether12331.40.5
26Carvacrol methyl ether12421.70.3
29Bornyl acetate12880.2
34Myrtenyl acetate13270.2-
35α-Terpinyl acetate13511.43.8
36Carvacryl acetate13680.2
37Geranyl acetate13780.33.2
47Caryophyllene oxide15960.80.11.4
  1. RI* - Retention Index; OV – Origanum vulgare L.; SH– Satureja hortensis L.; TS – Thymus serpyllum L.; TV – Thymus vulgaris L.

According to the GC-MS analysis presented in this article, the concentration of phenolic monoterpenes was higher as compared to that of other compounds prevalent in the studied EOs. We found that oregano EO contained the highest amount of carvacrol (57.3%), 1,8-cineole and α-pinene (20.9%). Previous reports showed that in Polish oregano cultures, the main components of the EOs were carvacrol, thymol and γ-terpinene [22]. The carvacrol content of different chemotypes of oregano EO is variable and it can be up to 95% [8]. Among the compounds identified in summer savory EO, carvacrol (50.7%) and also γ-terpinene and p-cymene (36.7%) were largely prevalent. This chemotype of the EO cultivated in Poland is very similar to the chemotype of the oil obtained from wild savory that is cultivated in Iran [23]. EOs from savory oil contain variable amounts of the main components to which thymol, carvacrol, as well as γ-terpinene and p-cymene belong [24]. As this paper suggests, wild thyme oil contains a large percentage of linalool (30.9%) and thymol (25.1%), plus geraniol and p-cymene (15.8%). Interestingly, this chemotype is a less frequent chemotype [25,26]. In the study of Wesołowska at al. [26], EOs isolated from wild thyme were composed mainly from carvacrol, γ-terpinene, p-cymene and β-caryophyllene. In other studies, a high content of thymol [27], γ-terpinene [28] or geraniol [25] was found. In contrast, the thyme EO showed a large content of thymol (75.2%), carvacrol (7.7%) and their precursor, p-cymene (6.3%). The composition of this EO is typical for the thymol chemotype. According to other authors [29,30], several chemotypes of thyme, based on EOs compositions, have been established, while the thymol chemotype is very common among essential Polish oil crops [31].

3.2 Antifungal assay

The obtained results were summarized in Tables 2, 3 and 4. The listed estimations of MIC50, MIC90, MFC50 and MFC90 allowed the sensitivity to EOs of the population of Candida spp to be assessed. Our results showed that the reference strains of C. albicans and C. glabrata, as well as the oral cavity isolates, were inhibited and killed by all tested EOs. MIC ranged from 125 to 2000 mg/ L and MFC ranged from 125 to 4000 mg/L, depending on the yeast and plant species. Moreover, the MFC/ MIC ratio was 1 to 4, indicating that the studied EOs held a positive fungicidal effect. The effect of the selected EOs on the studied oral isolates was similar. The values of MIC50, MIC90, MFC50 and MFC90 were in the range of 250 – 500 mg/L for oregano, savory and thyme EOs, while higher values were obtained for wild thyme EO.

Table 2

The activity of the tested essential oils against reference strains of Candida albicans and C. glabrata.

C. albicans ATCC 2091C. albicans ATCC 10231C. glabrata ATCC 90030
Positive controls
  1. The values of MIC and MFC were expressed in mg/L; NY: nystatin; CHX: chlorhexidine; OV: Origanum vulgare L.; SH: Satureja hortensis L.; TS: Thymus serpyllum L.; TV: Thymus vulgaris L.

Table 3

The activity of the tested essential oils against Candida albicans isolates from oral cavity.

EOsRange of MIC[*]MIC50MIC90Range of MFC[*]MFC50MFC90MFC/MIC
OV250 – 500250500250 – 5005005001 – 2
SH250 – 500250500250 – 5002505001 – 2
TS500 – 100050010001000 – 2000100020001 – 4
TV125 – 500250500250 – 5002505001 – 2
Positive controls
CHX1.98 – 7.813.917.811.98 – 15.627.8115.621 – 8
NY0.06 – 0.480.240.480.12 – 0.480.240.481 – 2
  1. Explanations as above

Table 4

The activity of the tested essential oils against Candida glabrata isolates from oral cavity.

EOsRange of MIC[*]MIC50MIC90Range of MFC[*]MFC50MFC90MFC/MIC
OV250 – 500250500500 – 10005005001 – 2
SH250 – 5005005005005005001 – 2
TS500 – 2000100020001000 – 4000200040001 – 4
TV125 – 250250250250 – 5005005001 – 2
Positive controls
CHX1.98 – 7.813.917.813.91 – 31.2515.6215.621 – 8
NY0.06 – 0.480.240.480.12 – 0.980.480.981 – 4
  1. Explanations as above

Among the tested EOs, thyme oil, was the most active, with MIC ranging from 125 – 500 mg/L and 125 – 250 mg/ L against oral isolates of C. albicans and C. glabrata, respectively. In turn, the value of MFC was in the range of 250 – 500 mg/ L and MFC/ MIC in the range of 1 – 2 towards isolates of both Candida species. The values of MIC50, MIC90, MFC50 and MFC90 were in the range of 250 – 500 mg/ L.

We found that all tested EOs showed activity against yeasts belonging to C. albicans and C. glabrata reference strains and those isolated from the oral cavity of different groups of patients. These EOs were able to inhibit the growth of pathogenic yeasts and also killed them at the same or slightly higher concentrations (MFC/MIC in the range of 1 – 4), hence, indicating their fungicidal activity. The following order of EOs antifungal activity against oral isolates of C. albicans and C. glabrata was found as follows: thyme EO (MIC = 125 – 500 mg/ L) ≥ oregano EO (MIC = 250 – 500 mg/L) = summer savory EO (MIC = 250 – 500 mg/L) ≥ wild thyme EO (MIC = 500 – 1000 mg/L).

The thyme essential oil had the highest effect towards oral isolates of Candida spp. among the tested oils. Numerous investigations have reported it to be a highly antimicrobial compound [5,7,30,32,33]. Furthermore, Cosentino et al. [30] showed similar activity of thyme EO (MIC = MFC = 225 – 450 mg/L) as reported above. In turn, the study of Al-Shahrani et al. [32] exhibited a much lower antifungal activity (MIC = 500 – 10 000 mg/ L and MFC = 2 500 – 10 000 mg/ L). Perhaps, lower MIC and MFC values were associated with a lower content of active ingredients in the EO. However, this cannot be confirmed because the authors did not analyze the chemical composition. A particularly high activity of this oil with MIC = 16.3 mg/ L against C. albicans was demonstrated by Fani et al. [33]. In contrast, other results [7] indicated that thyme EO was not able to inhibit the growth of the C. glabrata isolates at the tested concentrations (MIC > 3200 mg/ L). However, Giordani et al. [5] assessed the potential effect of various chemotypes of thyme EOs against C. albicans and showed that the thymol chemotype was the most active, with a MIC 80% of 14.7 mg/ L, wherein the efficacy was mainly due to the high level of thymol (63.2%). This aligns with our data.

The antifungal effect of the remaining EOs showed a lower activity against the oral isolates of C. albicans and C. glabrata compared to that of the thyme oil. According to other data, the values of MIC of oregano EO against strains of Candida spp. differentiated, ranging from 62.5 to 1600 mg/ L [7,34,35, 36, 37, 38, 39]. Our data are consistent with the earlier studies by other authors [34,39] who showed that MIC of O. vulgare EO ranged from 62.5 to 500 mg/ L against clinical C. albicans strains. Çoşkun et al. [35] found that the oil was also very effective against different strains of Candida spp. and its values of MIC were relatively low, ranging between 62.5 – 125 mg/ L. Moreover, Delić et al. [37] compared the activity of oregano oil against C. albicans indicating MIC at 110 mg/ L and MFC at 230 mg/ L. Vahedi G. et al. [36] revealed that the MIC of oil for C. glabrata isolates obtained from healthy individuals and patients with oropharyngeal candidiasis were between 150 – 200 mg/ L and 150 – 250 mg/ L, respectively. In turn, Pozzatti et al. [38] observed values in the range of 400 to 800 mg/ L for both parameters MIC and MFC, while Soares et al. [7] indicated that this EO showed varying levels of antifungal activity, with MIC ranging from 400 – 1600 mg/L and an even higher MFC ranging from 400 – 3200 mg/ L.

Our data are in agreement with these results. However, the results obtained by Sartoratto et al. [40] and by Ignatova-Ivanova et al. [41] showed a much weaker oregano EO activity at 2000 mg/ L or even at 2500 mg/L against both C. albicans and C. glabrata strains. In contrast to our data, Adiguzel et al. [24] showed that summer savory oil had no activity against Candida spp. In turn, Wesołowska et al. [26] reported the significant activity of wild thyme oil, with values of MIC at 45.5 mg/ L and MFC at 91 mg/ L, against C. albicans. This is contrary to our results – which indicated a lower antifungal activity. However, there is little literature available that correlates the activity of these EOs against Candida spp. and their chemical composition.

In our study, there was no difference in the MIC ranges of EOs between C. albicans and C. glabrata isolates, but the MIC values of EOs against these strains from other studies varied extensively. These variations might be explained by the different chemical composition of the EOs and the type of isolates used in these investigations. According to İşcan [42], terpene alcohols, phenols aldehydes and ketones appeared to be the most active components of EOs, while terpene hydrocarbons and esters appeared to be the least active. The antimicrobial activity of EO constituents was ranked as follows: phenols > aldehydes > ketones > alcohols > esters > hydrocarbons [36]. The observed antimicrobial properties of the tested EOs may be related to the high content of the terpene alcohols and their high solubility ratio in both aqueous media and bio membranes due to the alcohol moiety. Some differences were observed regarding the antimicrobial effect of stereoisomers [42].

The tested EOs in our study, as mentioned earlier, were rich in the following compounds: thymol, carvacrol, p-cymene, α-pinene, geraniol, linalool, γ-terpinene and 1,8-cineole. The study of İşcan [42] indicated that the activity of thymol (MIC = 250 – 500 mg/ L), carvacrol and p-cymene (MIC = 250 – 500 mg/L) or α-pinene (MIC = 500 – 1000 mg/L) was similar compared to the C. albicans and C. glabrata strains. Herein, geraniol possessed a particularly high activity, with MIC ranging from 60 to 500 mg/L and 1000 mg/L compared to C. albicans and C. glabrata, respectively, while linalool showed a slightly weaker effect at MIC = 500 – 1000 mg/L and 2000 mg/L towards C. albicans and C. glabrata, respectively. In turn, 1,8-cineole and γ-terpinene had the lowest activity, with MIC ranging from 2000 – 4000 mg/L and 4000 mg/L against C. albicans at 2000 mg/ L or 8000 mg/ L relating to C. glabrata, respectively.

Taking into account the chemical composition of the studied EOs, it is clear that there is a relationship between the high activity of the thyme EO and the presence of phenolic components such as thymol, carvacrol and their precursor p-cymene [24,36]. Carvacrol was also one of the most important ingredients of oregano and summer savory EOs. In addition, linalool and thymol were found in wild thyme. The antifungal activity of these EOs could be explained by the higher percentage of these compounds. Furthermore, EOs oils are complex mixtures of numerous molecules, and it is to be determined whether their antimicrobial effect is the result of a synergism of all molecules or whether it reflects only those of the main molecules present at the highest levels based on gas chromatographic analysis. Therefore, it is possible that the activity of the main components is also modulated by other minor molecules [41].

The antifungal activity of these EOs may be altered by synergistic and antagonistic effects between some components because some authors reported the synergistic activity of carvacrol and thymol [36,41]. Moreover, p-cymene increases the antimicrobial activity of thymol or carvacrol [36].

The mode of action of these phenolic components, is mostly related to the reaction with the microbial cell membrane. They initiate modifying effects on the outer and inner membrane, interact with or unfold the outer membrane proteins, cause changes in cell membrane fluidity, increase the membrane permeability and leakage of necessary ions, and change the pH hemostasis. The mechanisms of their antifungal action are related to the disruption of the fungal cell wall integrity and weakening of the synthesis procedure of ergosterol [36].

Because the antimicrobial activity of EO seems to depend on the presence of certain components, it is important to note that their chemical composition can vary within the same species of plant due to, among other causes, the presence of different chemotypes, harvest times, and extraction methods [7]. In addition, differences in the activity of EOs may exist between reference Candida spp. strains and isolates from various clinical specimens from healthy individuals or hospitalized patients. Additional research is, therefore, needed to address the antimicrobial activity of the EO majority fractions, the synergism between different EOs and antifungal agents, and to test the susceptibility of other opportunistic fungal species [7].

Figure 1 Total ion chromatograms (TIC’s) of tested essential oils. OV: Origanum vulgare, SH: Satureja hortensis, TS: Thymus serpyllum, TV: Thymus vulgaris. (Number of compounds see Tab. 1).
Figure 1

Total ion chromatograms (TIC’s) of tested essential oils. OV: Origanum vulgare, SH: Satureja hortensis, TS: Thymus serpyllum, TV: Thymus vulgaris. (Number of compounds see Tab. 1).

Also, most of the oral Candida spp. isolates are rarely isolated on their own, and often exist as a community of microbes. They can, however, occur alone, eventually, in immunocompromised or hospitalized patients, and patients undergoing chronic antibiotic therapy. Therefore, the additional advantage of EOs is their general antibacterial activity. According to some authors [26,33,42], they show a very wide spectrum of activity against other human pathogens such as Gram-positive and Gram-negative bacteria but are relatively more active against Gram-positive than Gram-negative bacteria. The data of Fani et al. [33] revealed the strong inhibitory activity of these EOs on some oral bacteria, including Streptococcus pyogenes, Streptococcus mutans, and also the periodontopathic anaerobic Gram negative rods Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis that are the most prevalent etiological agents of periodontal diseases. However, generally, these components demonstrated better inhibitory effects on Candida strains than the bacteria [42].

Our results are of clinical importance since C. albicans is responsible for the great majority of the infections in patients with recurrent oral candidiasis. In addition, C. albicans is considered the most pathogenic species of the genus Candida [43] and C. glabrata is resistant to a majority of azole drugs.

Despite the fact that in vitro studies cannot be directly extrapolated to in vivo effects, the results suggest that the use of these EOs should be further explored. It is difficult to find any research on the activity of these EOs on human subjects; however, some studies were performed on rats [44]. In an immunosuppressed rat of oral candidiasis, carvacrol or eugenol treatment significantly reduced the number of colony counts sampled from the oral cavity of the treated rats, compared to the untreated control rats. Further studies are needed to evaluate the in vivo potential of EOs both in human and animal subjects.

4 Conclusions

The obtained results indicated that the studied EOs, due to the high content of phenolic monoterpenes compounds responsible for their antifungal activity, may be regarded as useful natural components within formulations applied for the prevention and treatment of oral candidiases. Moreover, these EOs can substitute for many common synthetic antifungal preparations.

  1. Disclosure of interest. The authors state they have no competing interest.


[1] Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, et al. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010 Jan;6(1):e1000713. PMID:2007260510.1371/journal.ppat.1000713Search in Google Scholar PubMed PubMed Central

[2] Hristova Y, Wanner J, Jirovetz L, Stappen I, Iliev I, Gochev V. Chemical composition and antifungal activity of essential oil of Hyssopus officinalis L. from Bulgaria against clinical isolates of Candida species. Biotechnol. & Biotechnol. Eq. 2015;29(3):592–601. in Google Scholar

[3] Brandolt TM, Klafke GB, Gonçalves CV, Bitencourt LR, Martinez AM, Mendes JF, et al. Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates. Braz J Microbiol. 2017 Jan - Mar;48(1):145–50. PMID:2775653910.1016/j.bjm.2016.09.006Search in Google Scholar PubMed PubMed Central

[4] Fidel PL Jr, Vazquez JA, Sobel JD. Candida glabrata review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans Clin Microbiol Rev. 1999 Jan;12(1):80–96. in Google Scholar PubMed PubMed Central

[5] Giordani R, Regli P, Kaloustian J, Mikaïl C, Abou L, Portugal H. Antifungal effect of various essential oils against Candida albicans Potentiation of antifungal action of amphotericin B by essential oil from Thymus vulgaris Phytother Res. 2004 Dec;18(12):990–5. in Google Scholar PubMed

[6] Sarac N, Ugur A. The in vitro antimicrobial activities of the essential oils of some Lamiaceae species from Turkey. J Med Food. 2009 Aug;12(4):902–7. PMID:1973519310.1089/jmf.2008.0089Search in Google Scholar PubMed

[7] Soares IH, Loreto ÉS, Rossato L, Mario DN, Venturini TP, Baldissera F, et al. In vitro activity of essential oils extracted from condiments against fluconazole-resistant and -sensitive Candida glabrata J Mycol Med. 2015 Sep;25(3):213–7. PMID:2628196510.1016/j.mycmed.2015.06.003Search in Google Scholar PubMed

[8] Sakkas H, Gousia P, Economou V, Petsios S, Papadopoulou C. Antifungal activity of four essential oils against Candida clinical isolates. Asian J. Ethnopharmacol. Med. Foods. 2016;02(01):22–5.Search in Google Scholar

[9] Waller SB, Cleff MB, Serra EF, Silva AL, Gomes AD, de Mello JR, et al. Plants from Lamiaceae family as source of antifungal molecules in humane and veterinary medicine. Microb Pathog. 2017 Mar;104:232–7.10.1016/j.micpath.2017.01.050Search in Google Scholar PubMed

[10] Diba K, Ghabaie K, Heshmatian B, Sharbatkhori M. Antifungal activity of Satureja hortensis alcoholic extract against Aspergillus and Candida species. J Med Plants Res. 2013;7(30):2271–4. in Google Scholar

[11] Mihajilov-Krstev T, Radnovic D, Kitic D, Stojanovic-Radic Z, Zlatkovic B. Antimicrobial activity of Satureja hortensis L. essential oil against pathogenic microbial strains. Biotechnol. & Biotechnol. Eq. 2009;23(4):1492–6. in Google Scholar

[12] Martino L, Bruno M, Formisano C, Feo V, Napolitano F, Rosseli S, Senatore F. Chemical composition and antimicrobial activity of the essential oils from two species of Thymus growing wild in southern Italy. Molecules 2009;14(11):4614–24.10.3390/molecules14114614Search in Google Scholar PubMed PubMed Central

[13] Höferl M, Buchbauer G, Jirovetz L, Schmidt E, Stoyanova A, Denkova Z, et al. Correlation of antimicrobial activities of various essential oils and their main aromatic volatile constituents. J Essent Oil Res. 2009;21(5):459–63. in Google Scholar

[14] Chavan PS, Tupe SG. Antifungal activity and mechanism of action of carvacrol and thymol against vineyard and wine spoilage yeasts. Food Control. 2014;46:115–20. in Google Scholar

[15] Baj T, Sieniawska E, Kowalski R, Wesolowskp M, Ulewicz-Magulska B. Effectiveness of the Deryng and Clevenger-type apparatus in isolation of various types of components of essential oil from the Mutelina purpurea Thell. Flowers. Acta Pol Pharm. 2015 May-Jun;72(3):507–15. PMID:26642659Search in Google Scholar

[16] Skalicka-Woźniak K, Walasek M, Ludwiczuk A, Głowniak K. Isolation of terpenoids from Pimpinella anisum essential oil by high-performance counter-current chromatography. J Sep Sci. 2013 Aug;36(16):2611–4. PMID:2374968010.1002/jssc.201300407Search in Google Scholar PubMed

[17] Linstrom PJ, Mallard WG, editors. NIST Chemistry WebBook, NIST Standard Reference Database Number 69. Gaithersburg (MD): National Institute of Standards and Technology; p. 20899.Search in Google Scholar

[18] European Committee for Antimicrobial Susceptibility Testing (EUCAST) determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. EUCAST discussion document E. Dis 5.1. Clin Microbiol Infect. 2003;9:1–7.10.1046/j.1469-0691.2003.00790.xSearch in Google Scholar

[19] Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2012. pp. M27–S4.Search in Google Scholar

[20] Laczkowski K, Misiura K, Biernasiuk A, Malm A, Siwek A, Plech T. Synthesis, antimicrobial activities and molecular docking studies of novel 6-hydroxybenzofuran-3 (2H)-one based 2, 4-disubstituted 1, 3-thiazoles. Lett Drug Des Discov. 2013;10:798–807. in Google Scholar

[21] Talebi S, Sabokbar A, Riazipour M, Saffari M. Comparison of the in vitro effect of chemical and herbal mouthwashes on Candida albicans Jundishapur J Microbiol. 2014 Dec;7(12):e12563. PMID:2574142910.5812/jjm.12563Search in Google Scholar PubMed PubMed Central

[22] Baj T, Sieniawska E, Ludwiczuk A, Widelski J, Kiełtyka-Dadasiewicz A, Skalicka-Woźniak K, et al. Thin-layer chromatography-fingerprint, antioxidant activity, and gas chromatography-mass spectrometry profiling of several Origanum L. species. JPC-J Planar Chromat. 2017;30(5):386–91. in Google Scholar

[23] Farzaneh M, Kiani H, Sharifi R, Reisi M, Hadian J. Chemical composition and antifungal effects of three species of SaturejaS. hortensisS. spicigera and S. khuzistanica essential oils on the main pathogens of strawberry fruit. Postharvest Biol Technol. 2015;109:145–51. in Google Scholar

[24] Adiguzel A, Ozer H, Kilic H, Cetin B. Screening of antimicrobial activity of essential oil and methanol extract of Satureja hortensis on foodborne bacteria and fungi. Czech J Food Sci. 2007;25(2):81–9. in Google Scholar

[25] Paaver U, Orav A, Arak E, Mäeorg U, Raal A. Phytochemical analysis of the essential oil of Thymus serpyllum L. growing wild in Estonia. Nat Prod Res. 2008 Jan;22(2):108–15. PMID:1807589410.1080/14786410601035118Search in Google Scholar PubMed

[26] Wesołowska A, Grzeszczuk M, Jadczak D, Nawrotek P, Struk M. Comparison of the chemical composition and antimicrobial activity of Thymus serpyllum essential oils. Not Bot Horti Agrobot Cluj-Napoca. 2015;43(2):432–8. in Google Scholar

[27] Nikolić M, Glamočlija J, Ferreira IC, Calhelha RC, Fernandes Â, Marković T, et al. Chemical composition, antimicrobial, antioxidant and antitumor activity of Thymus serpyllum L., Thymus algeriensis Boiss. and Reut and Thymus vulgaris L. essential oils. Ind Crops Prod. 2014;52:183–90. in Google Scholar

[28] Rasooli I, Mirmostafa SA. Antibacterial properties of Thymus pubescens and Thymus serpyllum essential oils. Fitoterapia. 2002 Jun;73(3):244–50. PMID:1204801910.1016/S0367-326X(02)00064-3Search in Google Scholar

[29] Satyal P, Murray BL, McFeeters RL, Setzer WN. Essential oil characterization of Thymus vulgaris from various geographical locations. Foods. 2016 Oct;5(4):1–12. PMID:2823116410.3390/foods5040070Search in Google Scholar PubMed PubMed Central

[30] Cosentino S, Tuberoso CI, Pisano B, Satta M, Mascia V, Arzedi E, et al. In-vitro antimicrobial activity and chemical composition of Sardinian Thymus essential oils. Lett Appl Microbiol. 1999 Aug;29(2):130–5. PMID:1049930110.1046/j.1472-765X.1999.00605.xSearch in Google Scholar

[31] Kowalski R, Wawrzykowski J. Effect of ultrasound‐assisted maceration on the quality of oil from the leaves of thyme Thymus vulgaris L. Flavour Fragrance J. 2009;24(2):69–74. in Google Scholar

[32] Al-Shahrani MH, Mahfoud M, Anvarbatcha R, Athar MT, Al Asmari A. Evaluation of antifungal activity and cytotoxicity of Thymus vulgaris essential oil, Phcog. Commn. 2017;7(1):34–40.10.5530/pc.2017.1.5Search in Google Scholar

[33] Fani M, Kohanteb J. In vitro antimicrobial activity of Thymus vulgaris essential oil against major oral pathogens. J Evid Based Complementary Altern Med. 2017 Oct;22(4):660–6. PMID:2839755210.1177/2156587217700772Search in Google Scholar PubMed PubMed Central

[34] Adams A, Kumar S, Clauson J, Sahi S. Anti-yeast activities of Origanum oil against human pathogenic yeasts. Adv Biosci Biotechnol. 2011;2(2):103–7. in Google Scholar

[35] Çoşkun F, Sivri G, Demirci AŞ. Anti-Yeast effects of some commercial essential oils against food-related yeasts. IOSR J Environ Sci Toxicol Food Technol. 2016;10(11):83–8.Search in Google Scholar

[36] Vahedi G, Khosravi AR, Shokri H, Moosavi Z, Delirezh N, Sharifzadeh A, et al. Fungicidal effect of Origanum vulgare essential oil against Candida glabrata and its cytotoxicity against macrophages. J Herbmed Pharmacol. 2016;5(2):78–84.Search in Google Scholar

[37] Delić DN, Skrobonja JR, Karaman MA, Matavulj MN, Bogavac MA. Antifungal activity of essential oils of Origanum vulgare and Rosmarinus officinalis against three Candida albicans strains. Matica Srpska J Nat Sci. 2013;124(124):203–11. in Google Scholar

[38] Pozzatti P, Scheid LA, Spader TB, Atayde ML, Santurio JM, Alves SH. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp. Can J Microbiol. 2008; 54(11):950–6. PMID:1899785110.1139/W08-097Search in Google Scholar

[39] Esen G, Azaz AD, Kurkcuoglu M, Baser KH, Tinmaz A. Essential oil and antimicrobial activity of wild and cultivated Origanum vulgare L. subsp. hirtum (Link) letswaart from the Marmara region, Turkey. Flavour Fragrance J. 2007;22(5):371–6. in Google Scholar

[40] Sartoratto A, Machado AL, Delarmelina C, Figueira GM, Duarte MC, Rehder VL. Composition and antimicrobial activity of essential oils from aromatic plants used in Brazil. Braz J Microbiol. 2004;35(4):275–80. in Google Scholar

[41] Ignatowa-Ivanova T, Yotova I, Ivanov R. In vitro study of biological activity essential oil of Origanum vulgare L. subsp. vulgare L. J Chem Pharm Res. 2016;8(7):958–62.Search in Google Scholar

[42] İşcan G. Antibacterial and anticandidal activities of common essential oil constituents. Rec Nat Prod. 2017;11(4):374–88.Search in Google Scholar

[43] Cleff MB, Meinerz AR, Xavier M, Schuch LF, Schuch LF, Araújo Meireles MC, et al. In vitro activity of Origanum vulgare essential oil against Candida species. Braz J Microbiol. 2010 Jan;41(1):116–23. PMID:2403147110.1590/S1517-83822010000100018Search in Google Scholar

[44] Chami N, Bennis S, Chami F, Aboussekhra A, Remmal A. Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiol Immunol. 2005 Apr;20(2):106–11. PMID:1572057110.1111/j.1399-302X.2004.00202.xSearch in Google Scholar PubMed

Received: 2019-10-12
Accepted: 2019-12-17
Published Online: 2020-03-10

© 2020 Tomasz Baj et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 1.6.2023 from
Scroll to top button